Ginger Constantine, M.D.

Ginger Constantine, MD – Chairperson and CEO - with over 25 years of pharmaceutical regulatory and clinical development experience with the approval of more than 15 products filing numerous INDs, NDAs, and MAAs. Previous Vice President of Women's Health & Bone Repair Clinical Research at Wyeth Pharmaceuticals through its acquisition by Pfizer in 2010. Expertise in Phase 1 through 4 clinical development strategy and execution.

​

Founded EndoRheum Consultants in 2010, a successful clinical development consulting firm. Member of multiple scientific advisory boards. Has planned, authored and presented numerous scientific studies.